FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks
43.70 Fr
+0.100 (+0.229%)
At Close: May 31, 2024
Forecast Earnings Dividends Fundamentals Insider Trading Signals Historical Prices Predictions Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About Basilea Pharmaceutica AG

Basilea Pharmaceutica AG Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union, as well as in Phase III clinical trials for invasive fungal infections in Jap... BSLN.SW Profile

Golden Star

Ticker Date Change Price
GNTX May 28 0.93% $34.43
OHI May 20 2.20% $30.86
TTWO May 16 9.38% $146.08
RL May 15 11.06% $166.98
HLN May 13 1.58% $8.25
BJRI May 10 4.18% $33.75
DYN May 10 20.00% $26.00
NVO May 08 4.82% $126.69
WMT May 06 8.38% $59.87
JPM May 06 3.82% $192.00
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT